United Therapeutics Corp (UTHR)
272.22
-0.47
(-0.17%)
USD |
NASDAQ |
May 16, 16:00
271.01
-1.21
(-0.44%)
After-Hours: 20:00
United Therapeutics Free Cash Flow (Quarterly): 338.30M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 338.30M |
December 31, 2023 | 72.00M |
September 30, 2023 | 280.50M |
June 30, 2023 | 61.60M |
March 31, 2023 | 333.50M |
December 31, 2022 | 88.70M |
September 30, 2022 | 189.80M |
June 30, 2022 | 110.00M |
March 31, 2022 | 275.20M |
December 31, 2021 | 104.00M |
September 30, 2021 | 162.30M |
June 30, 2021 | 131.90M |
March 31, 2021 | 79.20M |
December 31, 2020 | 113.90M |
September 30, 2020 | 235.10M |
June 30, 2020 | 145.80M |
March 31, 2020 | 201.60M |
December 31, 2019 | 77.80M |
September 30, 2019 | 171.80M |
June 30, 2019 | 112.60M |
March 31, 2019 | -652.50M |
December 31, 2018 | 33.60M |
September 30, 2018 | 196.00M |
June 30, 2018 | 126.30M |
March 31, 2018 | 238.10M |
Date | Value |
---|---|
December 31, 2017 | -113.60M |
September 30, 2017 | 236.50M |
June 30, 2017 | 49.80M |
March 31, 2017 | 215.20M |
December 31, 2016 | 153.90M |
September 30, 2016 | 219.60M |
June 30, 2016 | 115.30M |
March 31, 2016 | 116.80M |
December 31, 2015 | -6.00M |
September 30, 2015 | 196.70M |
June 30, 2015 | 37.20M |
March 31, 2015 | 105.10M |
December 31, 2014 | 88.40M |
September 30, 2014 | 194.89M |
June 30, 2014 | -67.32M |
March 31, 2014 | 91.92M |
December 31, 2013 | 91.01M |
September 30, 2013 | 129.88M |
June 30, 2013 | 79.01M |
March 31, 2013 | 93.46M |
December 31, 2012 | 83.95M |
September 30, 2012 | 86.72M |
June 30, 2012 | 43.75M |
March 31, 2012 | -2.697M |
December 31, 2011 | 52.38M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
61.60M
Minimum
Jun 2023
338.30M
Maximum
Mar 2024
164.28M
Average
138.85M
Median
Free Cash Flow (Quarterly) Benchmarks
Liquidia Corp | -25.49M |
Ligand Pharmaceuticals Inc | 16.18M |
Esperion Therapeutics Inc | 53.76M |
Vertex Pharmaceuticals Inc | 1.058B |
Heron Therapeutics Inc | -9.516M |